Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (Abili-T)
Does multiple sclerosis affect glucose tolerance?
[American Academy of Neurology, Washington, 18-25 April 2015].
Cannabis and Cannabinoids (PDQ®)
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.
Phenytoin: an old but effective antiarrhythmic agent for the suppression of ventricular tachycardia.
Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis.
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction.
Early detection of MS treatment complication may improve survival
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.
Erythrocyte membrane Fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.
Feedforward postural control in individuals with multiple sclerosis during load release.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Evidence that nuclear factor IA inhibits repair after white matter injury.
Neurologic complications of influenza.
Experimental autoimmune encephalomyelitis.
Abnormal Baseline Brain Activity in Patients with Multiple Sclerosis With Simple Spinal Cord Involvement Detected by Resting-State Functional Magnetic Resonance Imaging.
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.
Averting inflammation by targeting the cytokine environment.
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium.
A nurse-led mental health service for people with multiple sclerosis.
Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.

Pages